Norden Gregory
SEC insider (Form 3/4/5 filer). CIK 0001405104. Director at Praxis Precision Medicines, Inc. (PRAX) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in NEW YORK, NY.
Companies Norden Gregory has filed insider reports for
- Praxis Precision Medicines, Inc. (PRAX): Director
- Royalty Pharma plc (RPRX): Director
- Zoetis Inc. (ZTS): Director
Norden Gregory
CIK: 0001405104
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
AwardDirect1.4K shares- - Jun 5, 2026RPRX
Royalty Pharma plc
AwardDirect4.5K shares- - May 14, 2026RPRX
Royalty Pharma plc
SaleDirect3K shares at avg. $53.00$161K - Mar 9, 2026ZTS
Zoetis Inc.
GiftDirect1.2K shares- - Feb 19, 2026ZTS
Zoetis Inc.
ExerciseDirect1.6K shares- - Feb 19, 2026ZTS
Zoetis Inc.
OtherDirect406 shares at avg. $127.28$52K - Feb 18, 2026ZTS
Zoetis Inc.
AwardDirectRestricted Stock Unit
1.9K shares- - Aug 11, 2025RPRX
Royalty Pharma plc
SaleDirect33.5K shares at avg. $36.23$1.2M - Aug 8, 2025RPRX
Royalty Pharma plc
ConversionDirect144.7K shares- - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
AwardDirectStock Option (Right to Buy)
10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award | 1,371 | - | $0 | Direct |
| Jun 5, 2026 |  RPRX Royalty Pharma plc | Award | 4,545 | - | $0 | Direct |
| May 14, 2026 | RPRX Royalty Pharma plc | Sale | 3,045 | $53.00 | $161,385 | Direct |
| Mar 9, 2026 |  ZTS Zoetis Inc. | Gift | 1,213 | - | $0 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Exercise | 1,619 | - | $0 | Direct |
| Feb 19, 2026 | ZTS Zoetis Inc. | Other | 406 | $127.28 | $51,676 | Direct |
| Feb 18, 2026 | ZTS Zoetis Inc. | Award Restricted Stock Unit | 1,936 | - | - | Direct |
| Aug 11, 2025 | RPRX Royalty Pharma plc | Sale | 33,500 | $36.23 | $1,213,749 | Direct |
| Aug 8, 2025 | RPRX Royalty Pharma plc | Conversion | 144,660 | - | - | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award Stock Option (Right to Buy) | 10,520 | - | - | Direct |
1-10 of 17 transactions